
Supplemental material, sj-jpg-2-tam-10.1177_17588359221119318 for Efficacy and safety of selpercatinib in Chinese patients with advanced RET-altered thyroid cancers: results from the phase II LIBRETTO-321 study by Xiangqian Zheng, Qinghai Ji, Yuping Sun, Minghua Ge, Bin Zhang, Ying Cheng, Shangtong Lei, Feng Shi, Ye Guo, Linfa Li, Lu Chen, Jingxin Shao, Wanli Zhang and Ming Gao in Therapeutic Advances in Medical Oncology
Oncology and Carcinogenesis not elsewhere classified, Aged Health Care, Respiratory Diseases, Pharmacology and Pharmaceutical Sciences not elsewhere classified
Oncology and Carcinogenesis not elsewhere classified, Aged Health Care, Respiratory Diseases, Pharmacology and Pharmaceutical Sciences not elsewhere classified
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
